IFG Advisory’s VanEck Pharmaceutical ETF PPH Stock Holding History

IFG Advisory’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$191K	Buy	+1,751	New	+$181K	0.01%	883
2023 Q1	–	Sell	-4,199	Closed	-$326K	–	522
2022 Q4	$326K	Buy	+4,199	New	+$310K	0.03%	382

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

IFG Advisory's PPH Position: Q2 2026 in Review

IFG Advisory opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 1,751 shares worth $191K. The stake represents 0.01% of the portfolio and ranks #883 among its holdings. This is a return to the name: IFG Advisory previously reported a position in PPH as recently as Q4 2022.

IFG Advisory first reported a position in PPH in Q4 2022 and has held it in 2 quarters since. The position peaked at $326K in Q4 2022. 147 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

IFG Advisory held 1,751 shares of VanEck Pharmaceutical ETF worth $191K as of Q2 2026.
VanEck Pharmaceutical ETF was a new IFG Advisory position in Q2 2026.
VanEck Pharmaceutical ETF made up 0.01% of IFG Advisory's portfolio in Q2 2026, its #883 holding.
IFG Advisory first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and has held it in 2 quarters since.
IFG Advisory's VanEck Pharmaceutical ETF position peaked at $326K in Q4 2022.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.